DRD5 anticorps (3rd Cytoplasmic Domain)
Aperçu rapide pour DRD5 anticorps (3rd Cytoplasmic Domain) (ABIN1733787)
Antigène
Voir toutes DRD5 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- 3rd Cytoplasmic Domain
-
Specificité
- Reacts with human DRD5 / Dopamine Receptor D5
-
Réactivité croisée (Details)
- BLAST analysis of the peptide immunogen showed no homology with other human proteins.
-
Purification
- Antigen affinity purified
-
Immunogène
- Synthetic 16 amino acid peptide from 3rd cytoplasmic domain of human DRD5 / Dopamine Receptor D5. Percent identity with other species by BLAST analysis: Human (100%), Gorilla (100%), Gibbon (100%), Monkey (100%), Dog (100%), Marmoset (94%)...
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
Working dilution: IHC - P (20 μg/mL)
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS, Sodium azide 0.1 %
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C/-80 °C
-
Stockage commentaire
- Long term: -70°C, Short term: +4°C
-
-
- DRD5 (Dopamine Receptor D5 (DRD5))
-
Autre désignation
- DRD5 / Dopamine Receptor D5
-
UniProt
- P21918
-
Pathways
- Regulation of Systemic Arterial Blood Pressure by Hormones, cAMP Metabolic Process, Regulation of long-term Neuronal Synaptic Plasticity
Antigène
-